Apollo's $20 billion for DePuy Synthes is roughly what J&J paid for Synthes alone.
Bloomberg says Apollo is in talks to buy J&J's orthopaedics business for close to $20 billion. In 2012 J&J paid $19.7 billion for Synthes, and DePuy was not included.
Bloomberg says Apollo is in talks to buy J&J's orthopaedics business for close to $20 billion. In 2012 J&J paid $19.7 billion for Synthes, and DePuy was not included.
The scheme needed 75% and got 78%. The loudest rebels had already sold to the arbs, and arbs vote yes.
Fifteen agencies, twelve PE vertical pages, two products under one label, and zero pages that say who owns the ad accounts at the end.
Boehly and Walter leave Chelsea at roughly a gilt yield, and the only buyer permitted to pay was the one already holding 61.5%. The record deal of 2022 has become the record price of 2026.